A carregar...
Current neoadjuvant treatment options for HER2-positive breast cancer
Approximately one quarter of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, the expression of which is associated with a relatively poor prognosis independent of other clinical and pathologic variables. Trastuzumab, a humanized recombinant m...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3156251/ https://ncbi.nlm.nih.gov/pubmed/21847344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S22917 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|